Managing threats rather than risks in blood transfusion: Robust design for a complex system

Transfusion

Volumn 46, Issue 11, 2006, Pages 2011-2013

  Murphy, William ^a  

^a IRISH BLOOD TRANSFUSION SERVICE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; HEALTH CARE POLICY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NOTE; RISK ASSESSMENT;

BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; HUMANS; RISK MANAGEMENT;

EID: 33750314488     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.01010.x     Document Type: Note

References (19)

1. May RM. Sociobiology: a new synthesis and an old quarrel. Nature 1976;260:390-2.
2. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
3. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
4. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000;406:583-4.
5. Ironside JW, Bishop MT, Connolly K, et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 2006;332:1186-8.
6. Klein MA, Frigg R, Flechsig E, et al. A crucial role for B cells in neuroinvasive scrapie. Nature 1997;390:687-90.
7. Ricketts K, Wilson MD. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease. Transfusion 2004;44:1475.
8. Sime SL. Strengthening the service continuum between transfusion providers and suppliers: enhancing the blood services network. Transfusion 2005;45:206S-223S.
9. Flesland O. Perspective on Nordic views on selective/universal leukodepletion. Transfus Sci 1998;19:355-7.
10. Mitka M. Blood groups differ on donor deferral. JAMA 2001;285:1694-5.
11. Hoey J. Human rights, ethics and the Krever inquiry. CMAJ 1997;157:1231.
12. Liability for defective blood products: A and Others versus National Blood Authority and Another [law report]. Times 2001;Apr 4.
13. Finlay TA. Report of the Tribunal of Inquiry into the Blood Transfusion Service Board. Dublin: Government Stationery Office; 1997.
14. Moreno JD. "Creeping precautionism" and the blood supply. Transfusion 2003;43:840-2.
15. Gell-Mann M. What is complexity [monograph]. Santa Fe (NM): Santa Fe Institute; 1995. Available from: http://www.santafe.edu/sfi/people/mgm/ complexity.html
16. Jen E. Stable or robust? What's the difference? In: Jen E, editor. Robust design. Oxford: Oxford University Press; 2005.
17. de Visser JA, Hermisson J, Wagner GP, et al. Perspective: evolution and detection of genetic robustness. Evol Int J Org Evol 2003;57:1959-72.
18. Voight CA, Mayo SL, Wang ZG, Arnold F. Directing the evolvable: utilizing robustness in evolution. In: Jen E, editor. Robust design. Oxford: Oxford University Press; 2005.
19. Robertson DS. Feedback theory and Darwinian evolution. J Theor Biol 1991;152:469-84.